PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy): a randomised crossover clinical trial comparing bolus fluorouracil/leucovorin [folinic acid] to capecitabine as treatment for moderate to high risk resected colorectal cancer.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 27 Jul 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Capecitabine (Primary) ; Fluorouracil; Folinic acid
Indications Colorectal cancer
Focus Therapeutic Use
Acronyms PACT

Most Recent Events

26 Jul 2020 Status changed from active, no longer recruiting to completed.
29 Oct 2009 Additional trial identifier (1594) identified as reported by United Kingdom Clinical Research Network).
29 Oct 2009 Status changed from discontinued to active, no longer recruiting as reported by United Kingdom Clinical Research Network)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight